[Randomized controlled trial of guided therapy carbohydrate antigen 125 in patients discharged from acute heart failure: effect on mortality at 1 year.] Ensayo aleatorizado controlado sobre la terapia guiada por el antigeno carbohidrato 125 en los pacientes dados de alta por insuficiencia cardiaca aguda: efecto sobre la mortalidad a 1 ano.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Heart failure therapies
- Indications Acute heart failure
- Focus Biomarker; Therapeutic Use
- Acronyms CHANCE-HF
- 04 Feb 2016 Biomarkers information updated
- 11 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported on ClinicalTrials.gov.
- 28 Feb 2012 New trial record